Showing results (121-130 of 183) with videos related to
Sort By:
Pageof 19
Controlled Clinical Trials|December 31, 2002
Women's angiographic vitamin and estrogen trial: design and methodsJudith Hsia, Edwin L Alderman, Joel I Verter, et al.JAMA|November 19, 2002
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trialDavid D Waters, Edwin L Alderman, Judith Hsia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2018
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)Scott R Evans, Dean Follmann, Ying Liu, et al.Plos Pathogens|October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeBruno B Andrade, Amrit Singh, Gopalan Narendran, et al.Medrxiv : the Preprint Server for Health Sciences|October 6, 2021
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant SurgeLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
Anti-PF4 antibodies associated with disease severity in COVID-19Qingbo Liu, Huiyi Miao, Shuai Li, et al.Vaccine|September 10, 2025
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trialDavid J Diemert, Daniel S Graciaa, Bo Zhang, et al.The New England Journal of Medicine|October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in LiberiaStephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.Pageof 19